News

The accelerated review procedure is granted infrequently by the EMA and so far it has not been awarded in the cardiovascular area. The decision on European Union (EU)

Actavis has begun shipping the product and, under applicable Hatch Waxman rules, is entitled to 180 days of marketing exclusivity. Intuniv is a prescription medicine used to treat

The grants awarded through the Foundation’s landmark Secure the Future initiative, which this year celebrates its 15th anniversary of providing community-based care and support to people living with

Teva was first to file, opening the generic market for the product, as well as making the product eligible for 180 days of marketing exclusivity. Exforge HCT (Amlodipine,

The IND filing for minocycline gel is part of the company’s strategy to develop improved drug delivery options for established drugs. Minocycline gel is a new formulation using

Supported by a grant from Eurostars, the project will combine Affibody’s proprietary platforms with Nordic’s radioimmunotherapy technology. Sweden’s Vinnova and the Norwegian Research Council have awarded around €1m

AVP-825 consists of low-dose sumatriptan powder delivered intranasally using a new Breath Powered delivery technology, for the treatment of migraine This delivery technology is activated by a user’s

aHUS is a severe and life-threatening ultra-rare disorder that affects around 200 people in England, with 20-30 new patients diagnosed with the condition each year. The disease causes

The results show that Immunoca® with statistical significance imparts a performance benefit of approximately 10 per cent in muscle strength. This is very relevant for healthy aging, as